Related Experiment Video

Updated: Aug 8, 2026

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
08:24

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

Towards a vaccine for Cryptococcus neoformans: principles and caveats

Kausik Datta1, Liise-anne Pirofski

  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

FEMS Yeast Research
|May 16, 2006
PubMed

Insights

A vaccine for cryptococcal disease is needed to prevent both acute and reactivated infections. This study discusses evidence supporting an antibody-mediated immunity approach for a Cryptococcus neoformans vaccine.

Area of Science:

  • Microbial pathogenesis
  • Immunology
  • Vaccine development

Background:

  • Cryptococcal disease results from host-microorganism interactions, with damage caused by Cryptococcus neoformans virulence factors or host responses.
  • Infection can be acute or reactivated from a latent state, necessitating a vaccine that addresses both scenarios.

Purpose of the Study:

  • To review the evidence supporting the development of a vaccine for Cryptococcus neoformans.
  • To explore the potential of inducing antibody-mediated immunity against cryptococcal disease.

Main Methods:

  • Literature review of existing evidence on Cryptococcus neoformans pathogenesis and vaccine strategies.
  • Analysis of data supporting antibody-mediated immunity in preventing cryptococcal infections.

Main Results:

  • Evidence suggests that Cryptococcus neoformans virulence factors and host responses contribute to disease pathology.
  • Antibody-mediated immunity is a viable strategy for preventing both acute and reactivated cryptococcal infections.

Conclusions:

  • A vaccine for Cryptococcus neoformans is crucial for preventing disease from both acute and latent infections.
  • Developing a vaccine that elicits antibody-mediated immunity holds significant promise for controlling cryptococcal disease.

More Related Videos

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...